UNSPSC 51152025: Decamethonium

This classification denotes a muscle relaxant with the molecular formula C16H38N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C1CG1S3T2W, chemically known as 1,10-decanediaminium, n,n,n,n',n',n'-hexamethyl but generally known as decamethonium bromide, which bears US NIH Compound Identifier 2968. European Medicines Agency schedules Decamethonium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01568MIG. The term DECAMETHONIUM is an International Non-Proprietary Name.

As of Q4 2014, DECAMETHONIUM remains the US FDA Preferred Term for this commodity. Decamethonium bears US NLM identifiers UMLS ID C0057231 and NCI Concept Code C77363. SMILES: C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C.

UNSPSC 51152025 Decamethonium is a Commodity code that captures pharmaceutical products and medical supplies state and local governments procure for health and emergency-response programs. However, recent opportunities posted under this code show a significant mismatch with its nominal scope — the actual solicitations involve naloxone kits, drug deactivation systems, and pharmacy benefit management services rather than decamethonium specifically. Issuing bodies on record include county health departments and state health and human services commissions, reflecting the code's application to community health procurement and opioid-response initiatives.

Seminole County, Florida issued an IFB in June 2026 (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to its Community Health Building and a two-year initial term with one-year renewal option. The Texas Health and Human Services Commission posted an RFI in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs and pharmacy benefit management arrangements, signaling exploratory procurement activity before formal competitive solicitation. The code shows limited recent activity tied to its stated pharmaceutical scope, and the opportunities present suggest that state and local procurement offices may be using this code for broader health-supply and pharmacy-services categories that extend beyond decamethonium itself.